Qiu T, Fu O
Front Mol Neurosci. 2025; 18:1536577.
PMID: 39974186
PMC: 11835808.
DOI: 10.3389/fnmol.2025.1536577.
Xie L, Hu B, Lu R, Cheng Y, Chen X, Wen J
Cell Res. 2025; 35(3):165-185.
PMID: 39875551
DOI: 10.1038/s41422-025-01078-8.
Xu B, Lawler K, Wyler S, Li L, Swati , Keogh J
Sci Transl Med. 2025; 17(781):eadr6459.
PMID: 39813316
PMC: 11797978.
DOI: 10.1126/scitranslmed.adr6459.
Semenova E, Guo A, Liang H, Hernandez C, John E, Thaker V
Pediatr Res. 2024; .
PMID: 39690244
DOI: 10.1038/s41390-024-03780-6.
Garvey W
Diabetes Spectr. 2024; 37(4):325-334.
PMID: 39649698
PMC: 11623045.
DOI: 10.2337/dsi24-0004.
Regulation of energy balance by leptin as an adiposity signal and modulator of the reward system.
Asgari R, Caceres-Valdiviezo M, Wu S, Hamel L, Humber B, Agarwal S
Mol Metab. 2024; 91():102078.
PMID: 39615837
PMC: 11696864.
DOI: 10.1016/j.molmet.2024.102078.
Monoallelic pathogenic variants in LEPR do not cause obesity.
Delplanque J, Le Collen L, Loiselle H, Leloire A, Toussaint B, Vaillant E
Am J Hum Genet. 2024; 111(12):2668-2674.
PMID: 39561769
PMC: 11639077.
DOI: 10.1016/j.ajhg.2024.10.014.
Descriptive analysis of MC4R gene variants associated with obesity listed on ClinVar.
Bayhaghi G, Karim Z, Silva J
Sci Prog. 2024; 107(4):368504241297197.
PMID: 39552559
PMC: 11571248.
DOI: 10.1177/00368504241297197.
Setmelanotide: A Melanocortin-4 Receptor Agonist for the Treatment of Severe Obesity Due to Hypothalamic Dysfunction.
Qamar S, Mallik R, Makaronidis J
touchREV Endocrinol. 2024; 20(2):62-71.
PMID: 39526054
PMC: 11548362.
DOI: 10.17925/EE.2024.20.2.9.
Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist.
Fontaine T, Busch A, Laeremans T, De Cesco S, Liang Y, Jaakola V
Nat Commun. 2024; 15(1):7029.
PMID: 39353917
PMC: 11445563.
DOI: 10.1038/s41467-024-50827-7.
Precision medicine for obesity: current evidence and insights for personalization of obesity pharmacotherapy.
Anazco D, Acosta A
Int J Obes (Lond). 2024; .
PMID: 39127792
DOI: 10.1038/s41366-024-01599-z.
An overview of benefits and risks of chronic melanocortin-1 receptor activation.
Bohm M, Robert C, Malhotra S, Clement K, Farooqi S
J Eur Acad Dermatol Venereol. 2024; 39(1):39-51.
PMID: 39082868
PMC: 11664455.
DOI: 10.1111/jdv.20269.
Melanocortin-4 Receptor PLC Activation Is Modulated by an Interaction with the Monocarboxylate Transporter 8.
Anthofer L, Gmach P, Uretmen Kagiali Z, Kleinau G, Rotter J, Opitz R
Int J Mol Sci. 2024; 25(14).
PMID: 39062808
PMC: 11277258.
DOI: 10.3390/ijms25147565.
Investigation of setmelanotide, an MC4R agonist, for obesity in individuals with Smith-Magenis syndrome.
Lazareva J, Sisley S, Brady S, Smith A, Elsea S, Pomeroy J
Obes Res Clin Pract. 2024; 18(4):301-307.
PMID: 38987029
PMC: 11427144.
DOI: 10.1016/j.orcp.2024.07.001.
Incorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic....
Ericson M, Freeman K, Larson C, Bouchard J, John K, Lunzer M
ACS Pharmacol Transl Sci. 2024; 7(4):1114-1125.
PMID: 38633589
PMC: 11020072.
DOI: 10.1021/acsptsci.4c00011.
MC4R Variants Modulate α-MSH and Setmelanotide Induced Cellular Signaling at Multiple Levels.
Rodriguez Rondon A, Welling M, van den Akker E, van Rossum E, Boon E, van Haelst M
J Clin Endocrinol Metab. 2024; 109(10):2452-2466.
PMID: 38567654
PMC: 11403317.
DOI: 10.1210/clinem/dgae210.
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.
Al Musaimi O
Biomolecules. 2024; 14(3).
PMID: 38540684
PMC: 10968328.
DOI: 10.3390/biom14030264.
The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management.
Fansa S, Acosta A
Diabetes Obes Metab. 2024; 26 Suppl 2:46-63.
PMID: 38504134
PMC: 11893075.
DOI: 10.1111/dom.15555.
Hypothalamic POMC neuron-specific knockout of MC4R affects insulin sensitivity by regulating Kir2.1.
Guo H, Xin Y, Wang S, Zhang X, Ren Y, Qiao B
Mol Med. 2024; 30(1):34.
PMID: 38448811
PMC: 10918880.
DOI: 10.1186/s10020-024-00804-z.
Immunogenetic Aspects of Sarcopenic Obesity.
Mazurkiewicz L, Czernikiewicz K, Grygiel-Gorniak B
Genes (Basel). 2024; 15(2).
PMID: 38397196
PMC: 10888391.
DOI: 10.3390/genes15020206.